translational research

SomaLogic was founded in 2000 with the goal of improving the well-being and quality of life of every individual by transforming how diseases were detected, diagnosed and managed. Building on decades of aptamer research, SomaLogic scientists developed a ground-breaking proteomics technology that overcomes the significant challenges of existing protein measuring technologies, with multiple applications across the biological and medical sciences. Their mission is to leverage our proprietary technology to create, develop and commercialize innovative life science research tools and breakthrough clinical products that transform healthcare.